Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How do you image when using DIBH with breast treatment?
Do you use portal or orthogonal imaging or both?
Answer from: Radiation Oncologist at Community Practice
For patients undergoing DIBH we use standard portal imaging only.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
VisionRT/OSMS daily with weekly standard ports
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
We use daily imaging of one tangential field . To minimize dose and exposure we only take one image of actual field and not double exposure with open field
Sign in or Register to read more
5160
5179
5178
Related Questions
Under what circumstances would you offer PMRT in a patient with DCIS?
Would you omit radiation for an elderly woman with bilateral breast cancers (both early-stage disease and ER+/PR+/HER2 negative) who otherwise meets the criteria for endocrine therapy alone?
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
Do you consider chest wall constraints when treating with 5-fraction APBI?
What is your preferred method of surveillance after mastectomy?
Are there additional risks associated with PMRT for a patient with prior lympho-venous bypass surgery?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?